UBS Downgrades Amgen (AMGN) to Neutral
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $417.51 +0.77%
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 16 | New: 6
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 16 | New: 6
Join SI Premium – FREE
UBS downgraded Amgen (NASDAQ: AMGN) from Buy to Neutral.
For an analyst ratings summary and ratings history on Amgen click here. For more ratings news on Amgen click here.
Shares of Amgen closed at $152.31 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amgen (AMGN) PT Raised to $388 at Guggenheim
- Northcoast Downgrades MarineMax (HZO) to Neutral
- UBS Starts Nuvama Wealth Management (NUVAMA:IN) at Buy
Create E-mail Alert Related Categories
Downgrades, Hot DowngradesRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
